To main content To main navigation

More-EUROPA Webinars

AI and ML approaches to identify and appraise registries and relevant data
AI and ML approaches to identify and appraise registries and relevant data
The More-EUROPA project is working towards a more efficient use of real-world data in the development, registration, and assessment of medicinal products in Europe. It focuses on the value and use of registry-based real-world data in augmenting clinical trial data in the regulatory and health technology assessment decision-making process.
The second More-EUROPA webinar on how AI and ML approaches can be used to identify and appraise registries and relevant data was held on the 9th of July 2024.

During this session, the following topics were discussed:
  • How AI and ML can help organisations in optimising their processes
  • How AI and ML can help regulators and HTAs in their decision-making
  • The AI-driven tool developed in the context of More-EUROPA
The information slides (.pdf) that were presented during the webinar can now be viewed.

You can also watch the webinar online (YouTube video):

AI and ML approaches to identify and appraise registries and relevant data

Play video
Video

To view this content, please accept our social media cookies

Watch video Scan QR-code
This is the 2nd in a series of webinars and future topics will include:
 
  • How RWD elements can augment clinical trial performance, and how to use registries as a source for external comparator data;
  • Methods to access registry data, data sharing (consent and privacy), and federated analyses;
  • How to evaluate and design registry based RCTs. 
Catch up on the first webinar in our series:

Use of Registries in Regulatory Decision Making